Ipilimumab-induced renal granulomatous arteritis: a case report

Ipilimumab-induced renal granulomatous arteritis: a case report

Abstract Background Immune Checkpoint Inhibitors (ICPIs) are promising new drugs in treatment of advanced tumours targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) and programmed cell death protein-1 (PD1) or its ligand (PDL-1). Ipilimumab is a monoclonal antibody targeting the CTLA-4 receptor use...

Full description

Bibliographic Details
Main Authors: Mathilde Lemoine, Baptiste Dilly, Alexandre Curie, Vivien Hébert, Charlotte Laurent, Mélanie Hanoy, Steven Grangé, Dominique Guerrot, Arnaud François, Dominique Bertrand
Format: Article
Language:English
Published: BMC 2019-10-01
Series:BMC Nephrology
Subjects:
Acute kidney injury
Renal granulomatous arteritis
Immune checkpoint inhibitors
Ipilimumab
Immune related adverse events
Online Access:http://link.springer.com/article/10.1186/s12882-019-1552-2

Internet

http://link.springer.com/article/10.1186/s12882-019-1552-2

Similar Items